John Rex - UnitedHealth Group Ex CFO
| UNHH34 Stock | 51.82 1.32 2.61% |
Insider
John Rex is Ex CFO of UnitedHealth Group Incorporated
| Age | 61 |
| Phone | 952 936 1300 |
| Web | https://www.unitedhealthgroup.com |
UnitedHealth Group Management Efficiency
The company has return on total asset (ROA) of 0.0776 % which means that it generated a profit of $0.0776 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2535 %, meaning that it generated $0.2535 on every $100 dollars invested by stockholders. UnitedHealth Group's management efficiency ratios could be used to measure how well UnitedHealth Group manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Kingsley Wheaton | British American Tobacco | 50 | |
| Jos Melo | Energisa SA | 60 | |
| Otavio Lazcano | Qualicorp Consultoria e | 49 | |
| Rogerio Peres | Qualicorp Consultoria e | 56 | |
| Leonardo Arajo | Plano Plano Desenvolvimento | N/A | |
| Vittorio Cretella | The Procter Gamble | N/A | |
| Jerome Abelman | British American Tobacco | 59 | |
| Jos Pacheco | Odontoprev SA | 62 | |
| Matthew Janzaruk | The Procter Gamble | 49 | |
| Jack Bowles | British American Tobacco | 59 | |
| Franco Abelardo | Qualicorp Consultoria e | N/A | |
| Pedro Nocetti | Qualicorp Consultoria e | N/A | |
| Shailesh Jejurikar | The Procter Gamble | 56 | |
| Maurcio Botelho | Energisa SA | 63 | |
| Luiz Cappi | Odontoprev SA | 75 | |
| Renee Silveira | Plano Plano Desenvolvimento | N/A | |
| Johan Vandermeulen | British American Tobacco | 55 | |
| Rodrigo Uhlendorff | Plano Plano Desenvolvimento | N/A | |
| Ken Patel | The Procter Gamble | N/A | |
| Ana Carracedo | Qualicorp Consultoria e | N/A | |
| Andre Schulten | The Procter Gamble | 52 | |
Management Performance
| Return On Equity | 0.25 | |||
| Return On Asset | 0.0776 |
UnitedHealth Group Leadership Team
Elected by the shareholders, the UnitedHealth Group's board of directors comprises two types of representatives: UnitedHealth Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of UnitedHealth. The board's role is to monitor UnitedHealth Group's management team and ensure that shareholders' interests are well served. UnitedHealth Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, UnitedHealth Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Dirk McMahon, Pres COO | ||
| John Rex, Ex CFO | ||
| Zachary Sopcak, VP Relations | ||
| Jennifer Smoter, VP Officer | ||
| Rupert Bondy, Ex Officer | ||
| Sandeep Dadlani, Ex Officer | ||
| Sir Witty, CEO Director | ||
| Thomas Roos, VP Officer | ||
| Brian Thompson, Ex UnitedHealthcare | ||
| James Barry, Director Pennsylvania |
UnitedHealth Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is UnitedHealth Group a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.25 | |||
| Return On Asset | 0.0776 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 2.7 T | |||
| Shares Outstanding | 65.4 B | |||
| Price To Book | 6.68 X | |||
| Price To Sales | 8.35 X | |||
| Revenue | 322.13 B | |||
| Gross Profit | 79.62 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in UnitedHealth Stock
When determining whether UnitedHealth Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of UnitedHealth Group's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Unitedhealth Group Incorporated Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Unitedhealth Group Incorporated Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in UnitedHealth Group Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..